Abstract. While the influence of caffeine on the regulation of brain perfusion has been the subject of multiple publications, the mechanisms involved in that regulation remain unclear. To some extent, that uncertainty is a function of a complex interplay of processes arising from multiple targets of caffeine located on a variety of different cells, many of which have influence, either directly or indirectly, on cerebral vascular smooth muscle tone. Adding to that complexity are the target-specific functional changes that may occur when comparing acute and chronic caffeine exposure. In the present review, we discuss some of the mechanisms behind caffeine influences on cerebrovascular function. The major effects of caffeine on the cerebral circulation can largely be ascribed to its inhibitory effects on adenosine receptors. Herein, we focus mostly on the A1, A2A, and A2B subtypes located in cells comprising the neurovascular unit (neurons, astrocytes, vascular smooth muscle); their roles in the coupling of increased neuronal (synaptic) activity to vasodilation; how caffeine, through blockade of these receptors, may interfere with the "neurovascular coupling" process; and receptor-linked changes that may occur in cerebrovascular regulation when comparing acute to chronic caffeine intake.
INTRODUCTION
The widely-consumed psychostimulant, caffeine (1,3,7-trimethylxanthine) , displays a broad array of actions on the brain. There are multiple targets of caffeine, giving rise to a high level of complexity that can confound experimental efforts to understand caffeine influences in the brain. Despite such "impediments", a substantial body of literature has been accumulated in recent years that has provided some insights into the mechanisms of caffeine influence in the brain, with important clinical/translational implications. One example of the latter would be Alzheimer's disease (AD), as supported by evidence suggesting a positive influ- * Correspondence to: D.A. Pelligrino, Ph.D., Neuroanesthesia Research Laboratory, Department of Anesthesiology, University of Illinois at Chicago, 835 S. Wolcott Avenue, Room E-714C, Chicago, IL 60612, USA. Tel.: +1 312 355 1666; Fax: +1 312 355 1442; E-mail: dpell@uic.edu. ence of long-term caffeine intake on cognitive function in patients, especially memory and learning (e.g. [1] ). One possible contributing factor to the onset and progression of cognitive impairment in AD, is vascular dysfunction. In particular, this relates to pathologic changes in cerebral vascular tissue linked to accumulation of amyloid-β peptide (Aβ) in and around cerebral blood vessels, resulting in a condition labeled cerebral amyloid angiopathy (CAA). Some of the characteristics of CAA that are thought to contribute to exacerbation of AD pathology include impaired neurovascular coupling, cerebral hypoperfusion and hypercontractility, loss of cholinergic innervation, blood-brain-barrier damage, and microvascular ruptures [2] [3] [4] [5] . Of some relevance to the present discussion, Arendash and coworkers [6] recently published compelling data showing that chronic caffeine consumption was associated with reductions in cerebral Aβ levels, and cognitive improvement in AD mice. Since increased presence of Aβ may impair cerebral vascular function (see above), 
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it is tempting to postulate that caffeine could limit the severity of CAA and, perhaps, mitigate cognitive decline, via a vasculoprotective effect. However, such a mechanism remains to be established. Thus, in the remainder of this review, no further consideration will be given to caffeine-modulated vascular-AD linkages. Instead, we will focus primarily on acute and chronic caffeine influences on hemodynamic function, with some emphasis on neurovascular coupling (functional hyperemia).
CAFFEINE TARGETS RELATED TO CEREBRAL VASCULAR CONTROL
Caffeine influence on cerebral perfusion is likely to involve its interactions with targets in vascular cells (e.g., smooth muscle; endothelium) as well as nonvascular cells (e.g., neurons; astrocytes; microglia). The literature points to at least 4 targets of caffeine in the brain -adenosine receptors, cyclic nucleotide phosphodiesterases, ryanodine receptors, and GABA A receptors. With exception of the ryanodine receptors (activation), caffeine's influence on the above targets is inhibitory. Realistically, within the range of daily human caffeine consumption, among the caffeine-sensitive entities listed above, only the adenosine receptors may have any relevance, since caffeine possesses 1-2 orders of magnitude less potency toward the other targets listed [7] . Thus, the present review will focus only on caffeine effects on adenosine receptors and the implications of that interaction with respect to neurovascular coupling in particular.
NEUROVASCULAR COUPLING AND THE CONCEPT OF THE NEUROVASCULAR UNIT
The tight coupling between neuronal activity and blood flow is fundamental to brain function. When a specific brain region is activated, cerebral blood flow increases in a temporally and spatially coordinated manner, thereby improving substrate (glucose, O 2 ) delivery to meet local metabolic demands. Multiple signaling pathways have been shown to contribute to neurovascular coupling (reviewed in [8] [9] [10] [11] ). However, there appears to be a considerable degree of overlap in the mechanisms promoting the vasodilation accompanying increased neural activity, suggesting interactions among the signaling pathways. That complexity of the neurovascular signaling process, to a large degree, arises from the participation of multiple cells, principally neurons, astrocytes, and vascular cells (smooth muscle and endothelium), collectively termed the "neurovascular unit". Astrocytes, in fact, may represent the linchpin in transducing increased synaptic activity to local vasodilation. The important physiologic function of astrocytes in sensing neuronal activity and in turn regulating the tone of cerebral arterioles has been addressed by a number of investigators [8] [9] [10] [11] . Astrocytic endfeet extensively ensheath cerebral microvessels, to the extent that direct neuronal contacts to cerebral arterioles are sparse. Thus, astrocytes physically link neurons and their synapses with the vasculature, and are in a strategic position to convey neuronal signals to the blood vessels. As an example, neuronal activation can evoke increases in astrocytic [Ca 2+ ], which in turn may trigger certain enzymes or cell membrane channels to generate or release vasoactive compounds. In this review, owing to its relevance to caffeine influences, we consider only one such vasodilating pathway, one that is related to adenosine. Clearly, there are other astrocytic Ca 2+ -linked vasodilating mechanisms, for example, involving K + or arachidonic acid-derived mediators [8] [9] [10] [11] . The overall importance of astrocyte Ca 2+ regulation to the neurovascular coupling process is reflected in the impairment of that process following inhibition of certain astrocyte Ca 2+ -related pathways [12, 13] .
Increased synaptic activity has been linked to initiation of a propagated signal between astrocytes. Thus, a signal originating at the site of increased neural (synaptic) activity can be transmitted, over multiple astrocytes, to perivascular glial endfeet and elicit changes in arteriolar tone. Calcium, as reflected in the appearance of a "Ca 2+ wave" capable of traversing multiple astrocytes, appears to be a vital component in this signaling process. Other factors that may play important roles in the transmission of a neuronally-initiated vasodilating signal, via astrocytes, include excitatory neurotransmitters (e.g., glutamate), K + , and ATP released by activated neurons (see [11] ). There is evidence that ATP binds to purinergic receptors on neighboring astrocytes. These receptors are termed metabotropic purinergic receptors (labeled P 2Y in Fig. 1 ) by virtue of their linkage to phospholipase C activation, inositol trisphosphate generation, and the well-described release of Ca 2+ from intracellular stores (e.g. [14] ). This appears to play an important role in initiating and propagating the Ca 2+ wave. The appearance of ATP in the extracellular compartment also leads to rapid formation of adenosine. This Table 1 ). The glutamate released from the presynaptic terminal can effect post-synaptic activation via engaging metabotropic (mGluR) or ionotropic (NMDA and AMPA) receptors on post-synaptic dendrites . Post-synaptic activation of A 1 and A 2A receptors has been associated with repression of glutamate-linked post-synaptic function [22] . This could act as a "brake" on trans-synaptic signaling . The patterns of A 1 and A 2A receptor expression, as well as the neurotransmitters they modulate, vary among brain structures. Based upon information obtained from cerebrocortical synaptosomes (where evidence indicates the presence of both A 1 and A 2A receptor-mediated modulation of glutamate release [32, 34] ), the model depicted in Fig. 1 (and Fig. 2 ) could be taken to represent cerebral cortex. The figure depicts the presence of A 1 and A 2A receptors in close association with one another in the presynaptic nerve ending. This "heteromeric" arrangement represents one of several possibilities, including scenarios where the A 1 or A 2A receptor subtype predominates. In the heteromeric arrangement, it has been postulated that the Gs-linked A 2A receptor not only will activate adenylyl cyclase (AC), but also, via a PKA-independent mechanism [32, 34] , prevent the G i/ o -linked A 1 receptor from inhibiting AC, especially under conditions of increased neuronal activity and ADO availability [35] . One consequence of this will be a PKA-driven increased Ca 2+ influx at the presynaptic membrane, overcoming A 1 receptor-linked depression of voltage-dependent Ca 2+ entry [34] , thereby potentiating Ca 2+ -dependent glutamate/ATP release and extracellular ADO generation . Astrocytic Component. The released ATP and glutamate can interact with astrocyte metabotropic P 2Y receptors and mGluR's , respectively, leading to mobilization of Ca 2+ from intracellular storage sites within astrocytes . In addition, the increased presence of ADO, arising from the released ATP, activates A 2A receptors on astrocytes leading to cAMP/PKA-dependent mobilization of intracellular Ca 2+ from cellular stores . Adenosine interaction with astrocytic A 2A receptors also can contribute to blockade of the astrocytic glutamate import protein, GLT-1 ; and promote Ca 2+ -dependent enhancement of glutamate efflux . This should result in further elevations in glutamate levels in the synaptic cleft, as well as contributing to the astrocytic "Ca 2+ wave". The figure also speculates that a PKA-linked "boost" to the astrocytic Ca 2+ mobilization may arise from ADO binding to Gs-linked A 2B receptors . The "wave" of Ca 2+ generated by the combined influences of glutamatergic, purinergic P 2Y , and adenosinergic mechanisms will ultimately promote ATP release from astrocytes, including remote sites . ATP represents an important signaling molecule in astrocytes. It arises from cellular glucose and O 2 metabolism and can diffuse (along with Ca 2+ ) from astrocyte to astrocyte through gap junctions . Additionally, ATP represents perhaps the most important molecule involved in inter-astrocytic communication. Thus, Ca 2+ -dependent release of ATP from one astrocyte interacts with P 2Y receptors on adjacent astrocytes, contributing to the spread of the Ca 2+ wave. Arteriolar Component. The release of ATP in the vicinity of arterioles is likely to result in rapid formation of ADO and interactions with smooth muscle A 2 receptors. There is little doubt that cerebral arterioles are well-endowed with A 2 receptors. Both A 2 subtypes are likely to be present on cerebral resistance vessels; although the literature seems to favor the A 2A receptor, especially in intraparenchymal and pial arterioles [24, 50] . This is reflected in the figure. Principally, A 2 activation generates cAMP , which is not only capable of activating PKA, but cGMP-dependent protein kinase (PKG) as well [46, 70] . The increased kinase function is associated with phosphorylation and opening of K + channels , leading to smooth muscle cell hyperpolarization (↓Vm). This lowers intracellular Ca 2+ levels through a reduction in Ca 2+ influx via voltage-operated Ca 2+ channels. Elevated PKA/PKG function also is accompanied by a reduction in the Ca 2+ -sensitivity of contractile proteins (e.g., myosin ). The combination of reduced VSM Ca 2+ levels and diminished sensitivity to Ca 2+ leads to relaxation. See text for further discussion and additional citations. , along with the diminished contributions from metabotropic purinergic and glutamatergic receptors (arising from reduced extracellular ATP and glutamate levels ), a large reduction in the capacity to generate a Ca 2+ wave might be expected , resulting in less ADO being "presented" to VSM cells . The diminished ADO exposure, combined with caffeine blockade of VSM A 2 receptors , leaves little capacity remaining for ADO-mediated vasodilation. The potentially diminished capacity to effect "remote" increases in extracellular ADO could also interfere with heterosynaptic influences (see Fig. 1 legend) ; although the lack of relevant information does not permit any further discussion of this matter. The above speculation provides some (although not the only) possible explanations for the finding that acute caffeine administration profoundly attenuates the in vivo dilation of pial arterioles accompanying somatosensory activation in rats [54] .
is due to the ubiquitous presence of ecto-nucleotidases on astrocytic, vascular, and neuronal surfaces in the brain [15] [16] [17] [18] [19] , particularly ecto-nucleoside triphosphate diphosphohydrolase-1 (E-NTPDase-1) and ectonucleotide pyrophosphatase/phosphodiesterase (E-NPP), which mediate direct ATP to AMP conversions; and ecto-5'-nucleotidase, which catalyzes the subsequent formation of adenosine from AMP. In considering neurovascular coupling and the neurovascular unit, one cannot ignore the contributions from the pial arterioles that lie upstream from the parenchymal arterioles. Thus, although local dilation of parenchymal arterioles is important in adjusting nutrient supply to neuronal needs, that response could be ineffective in the absence of dilation in the pial arterioles. Indeed, during increased activity of cortical neurons, overlying pial arterioles dilate, despite the lack of any direct contact with activated neurons. In a recent report, we showed that astrocytes provide a key link between increased neuronal activity in the brain parenchyma and the remote arteriolar relaxation represented by pial arterioles [20] .
ADENOSINE RECEPTORS AND NEUROVASCULAR COUPLING
The role of adenosine and its receptors in the coupling of increased neuronal/synaptic activity to dilation Only applies to conditions of enhanced synaptic activity, where endogenous adenosine rises to levels sufficient to activate low-affinity A 2B receptors [7] . A 3 receptors are not considered.
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Limited cerebral A 3 expression [27] ; no direct vascular actions of A 3 receptor ligands [24] ; order-of-magnitude less sensitive to caffeine vs A 1 , A 2A , and A 2B receptors [7] . Caffeine blockade of A 1 receptors primarily reflects actions toward presynaptic sites; although post-synaptic sites cannot be ignored.
Although A 1 receptors exist on post-synaptic membranes, presynaptic expression may predominate [21] . A major consequence of presynaptic A 1 receptor activation is inhibition of neurotransmitter release [22] . Post-synaptic A 1 receptor activation may hyperpolarize post-synaptic elements, further restricting synaptic signaling. Astrocytic A 1 receptors are not considered.
Synaptic A 1 receptor expression exceeds astrocytic expression [21] ; reports are inconsistent regarding the manifestations of astrocytic A 1 receptor activation (e.g., intracellular Ca 2+ regulation [25, 26] ). Cerebral arterioles are devoid of functional A 1 receptor activity.
Direct applications of A 1 receptor ligands are without affect on cerebral arterial/arteriolar tone [24] . Caffeine influence on neurovascular coupling is likely to involve blockade of A 2A receptors expressed on pre-and post-synaptic membranes, astrocytes, and vascular cells.
Presynaptic A 2A receptor engagement can promote glutamate release both directly and via restricting A 1 receptor effects. Adenosine A 2A (and A 1 ) receptors on postsynaptic membranes are thought to depress glutamate receptor-mediated post-synaptic activation [22] . Post-synaptic expression of A 2A receptors may be of some importance in "heterosynaptic" regulation (see text), but is not assigned a major role in the synapse → astrocyte → arteriole signaling pathway. Caffeine blockade of A 2B receptors, during synaptic activation states, primarily reflects actions toward astrocytic and vascular sites.
Neuronal A 2B receptor expression is sparse [38, 39] . There is good evidence of A 2B receptor expression in astrocytes [22] . Although controversial, cerebral artery/arteriolar A 2B receptor expression and function may be less extensive than A 2A receptors [8, 24, 50] .
of arterioles and arteries, and how caffeine might influence that important physiologic response, is the central theme of this review. To facilitate the following discussion of this rather complex process, we have created two cartoons representing neurovascular coupling in the absence (Fig. 1) and presence (Fig. 2) of acute caffeine exposure. In constructing these cartoons, a number of simplifying assumptions were made regarding the interplay among the major components of the neurovascular unit (synapse, astrocyte, and arteriole), adenosinergic mechanisms, and the targets of caffeine. Those assumptions, along with their rationale, supporting evidence, and caveats are summarized in Table 1 .
Adenosine receptors, also referred to as purinergic P 1 receptors, consist of four known subtypes (A 1 , A 2A , A 2B , and A 3 ). These receptors are coupled to either G i/o (A 1 and A 3 ) or G s (A 2A and A 2B ) proteins, which, upon engagement with adenosine, results in inhibition or enhancement of adenylyl cyclase activity, respectively. Among the adenosine receptors, the A 1 receptor is the most regionally widespread in the brain. Evidence indicates that the A 1 receptor is enriched in synaptic membranes in relation to other cellular elements [21] , which is consistent with its purported neuromodulatory role. A prime example of that role is the ability of A 1 receptor activation to restrict presynaptic neurotransmitter release [22] . Furthermore, A 1 receptor agonists have been reported to have a far greater effect toward restricting glutamate vs GABA release, indicating that presynaptic A 1 activation is primarily anti-excitatory [22] . Although some cerebrovascular presence of A 1 receptors has been documented [23] , its functional significance is unclear, since direct applications of A 1 ligands do not affect cerebral arterial/arteriolar tone [24] . The A 1 receptor is expressed in astrocytes [25, 26] . However, results from in vitro models (primary cultures, acutely isolated astrocytes, or brain slices) have not yielded consistent findings. That is, A 1 receptor activation has been associated with PLC-linked intracellular Ca 2+ elevations in some situations [25] , but repression of Ca 2+ influx in others (e.g. [26] ). The A 3 receptor also is expressed in brain tissue, but with a limited distribution [27] . Although some expression of A 3 receptors has been found in brain blood vessels [23] , like the A 1 receptor, it does not appear to be associated with any direct hemodynamic function [24] . The A 3 receptor has also been detected in astrocyte in vitro preparations [25] , and may be involved in the regulation of astrocyte intracellular Ca 2+ [28] . The high affinity, A 2A , and low affinity, A 2B , receptors are expressed in cerebral resistance vessels (see, for example [24] ). Despite its lower adenosine affinity, recent findings [29] suggested that the A 2B receptor S56
D.A. Pelligrino et al. / Caffeine and Cerebral Blood Flow
plays a significant role in physiologic cerebral vasodilation. Some have speculated that the A 2A and A 2B receptors are differentially distributed within the cerebral arterial/arteriolar system, with A 2A receptors predominating in the upstream pial arterial/arteriolar segments and A 2B having greater influence in the downstream intraparenchymal segments [8] . However, others have reported a substantial A 2A receptor participation in adenosine-induced dilations in rat brain parenchymal arterioles [24] . Irrespective of segmental localization, adenosine engagement of the vascular A 2 receptors promotes vasodilation. Like A 1 receptors, A 2A receptors are found in presynaptic structures, but with a more limited regional distribution compared to A 1 receptors [30] . In rodents, the A 2A subtype exhibits the highest expression in the striatum, in keeping with its association with dopamine-rich structures, with comparatively low abundance (relative to A 1 ) in the cortex and hippocampus (e.g. [31] ). Nevertheless, the existence of A 2A receptors in the cortex is not insignificant, in light of evidence that glutamate release in rat cortical synaptosomes is enhanced by A 2A receptor activation [32] . In contrast to the hippocampus [30] and striatum [33] , the possibility of a cortical A 1 /A 2A colocalization has not been confirmed via immunohistochemistry. Nevertheless, the presence of both A 1 and A 2A receptors in cortical synaptic structures can be inferred from findings that evoked glutamate release from cortical synaptosomes exhibits a marked sensitivity to manipulations of A 1 and A 2A receptor function [32, 34] . One postulated manifestation of colocalization is the "heteromeric" A 1 /A 2A arrangement [31] . Thus, the higher levels of extracellular adenosine that are likely to be associated with conditions of elevated neuronal activity are thought to favor increased A 2A receptor function [35] . The activated A 2A receptor can, in turn, effect an inhibition of A 1 receptor function, via a mechanism involving protein kinase C, rather than cAMP-dependent protein kinase (PKA) [36, 37] . The A 2A receptor effect could also include a more conventional PKA-dependent mechanism that involves elevated presynaptic Ca 2+ entry [22] . The end result of these A 2A receptor-related actions is enhancement of glutamate release. Experimental evidence, obtained in synaptosomal preparations of rat cortex, hippocampus, and striatum, support an A 2A receptor crosstalk repression of A 1 receptor synaptic function that occurs across multiple cerebral structures [36, 37] .
With respect to A 2B receptors, evidence indicates a rather sparse neuronal presence in the brain [38, 39] . Although A 2B receptors are reasonably well-expressed in astrocytes and cerebral vascular cells [8, 22, 24, 40] , in view of the low affinity of A 2B receptors toward adenosine, any functional relevance may be limited to conditions of elevated extracellular adenosine presence, as may be found during higher neuronal activity states. The model depicted in Fig. 1 represents such a state. Therefore, A 2B receptors on astrocytes and vascular smooth muscle are given consideration (see also Table 1 ).
In astrocytes, at least two functions for A 2A receptors have been identified (see Fig. 1 ). Both of these functions are likely linked to activation of adenylyl cyclase and enhanced PKA-mediated phosphorylation. The first involves restriction of glutamate uptake, via inhibition of the astrocytic GLT-1 transporter [41] . The second A 2A receptor function relates to PKA-mediated release of Ca 2+ from astrocytic stores [42] . This not only can contribute to trans-astrocytic signaling (i.e., the "Ca 2+ wave"), but also promote Ca 2+ -dependent glutamate and ATP efflux (e.g. [41, [43] [44] [45] ). This will yield further elevations of glutamate and ATP in the synaptic cleft, potentiating neurotransmission [25, 40] and providing more ATP for extracellular adenosine generation. It also has been suggested that adenosine engagement of astrocytic A 2B receptors may provide a "boost" for the astrocytic Ca 2+ wave during neural activation states (see review by Koehler et al. [8] ). The A 2 receptor-associated potentiation of astrocytic signaling, provided by a more robust Ca 2+ wave, will ultimately enhance release of astrocytic ATP in the vicinity of arterioles. The ATP can then be rapidly converted to adenosine, which interacts with arteriolar smooth muscle A 2 receptors. The subsequent G s -mediated activation of smooth muscle adenylyl cyclase will increase intracellular cAMP levels and activate PKA (and, perhaps, cGMP-dependent protein kinase [PKG] [46] ), which in turn, can phosphorylate targets within the smooth muscle cells. One target is K + channels [47] , leading to K + efflux, thereby promoting smooth muscle hyperpolarization and reduced intracellular Ca 2+ levels. Another key group of phosphorylatable targets are myosin light chain phosphatase, myosin light chain kinase, and RhoA, with the result being a reduced sensitivity of contractile proteins to Ca 2+ [46, 48] . It should be emphasized that the signaling scheme provided by Fig. 1 applies both to local dilation of parenchymal arterioles, involving a single astrocyte, or upstream pial arteriolar dilation involving Ca 2+ /ATP (and perhaps K + ) -linked communication over multiple astrocytes (see [11, 20] ).
It is of some interest to note that if one replaces the vascular smooth muscle cell in Fig. 1 with another 
S57
synapse, interactions of adenosine with its receptors in that synapse could lead to synaptic depression. Such a process might be found in the "heterosynaptic depression" model proposed by Cunha [31] . Thus, an astrocytic Ca 2+ wave, arising as the result of synaptic activation at one locus, will ultimately result in the release of ATP and subsequent generation of adenosine at a remote astrocytic site. If that adenosine contacts an arteriole, vasodilation (neurovascular coupling) will occur. If another synapse is contacted instead, synaptic depression could occur. One might speculate that a possible contribution to that heterosynaptic depression could arise not only from the presence of A 1 receptors presynaptically, but also from the presence of A 1 and A 2A receptors on post-synaptic membranes of these distal synapses. Post-synaptic A 1 and A 2A receptors are thought, if anything, to be associated with attenuation of post-synaptic excitation (e.g., glutamatergic [22, 49] ). Thus, adenosine-related attenuation of post-synaptic function at remote (and even proximal) synapses could act to limit the spread of electrical activity from extending much beyond the area of initial activation. This might be viewed as an efficient way to ensure sufficient perfusion and substrate delivery to active neurons while limiting the amount of electrical "noise" (see Table 1 ). However, it merits mention that distribution of adenosine receptors between pre-and post-synaptic membranes may exhibit regional variations. For example, for A 2A receptors, evidence suggests post-synaptic localization being favored in the striatum, while a distribution favoring the presynaptic membrane appears to be the case in the cortex [49] . How such differences might affect heterosynaptic depression remains to be determined.
ACUTE CAFFEINE EFFECTS ON NEUROVASCULAR COUPLING
A scheme summarizing acute caffeine effects on neural activation-evoked arteriolar dilation is presented in Fig. 2 . A number of the simplifying assumptions listed in Table 1 relate specifically to caffeine influences. First, we assumed a roughly equivalent caffeine potency toward blocking A 1 , A 2A , and A 2B receptors [7] . However, despite that similarity, the A 2B receptors, owing to their low adenosine affinity, may be affected by caffeine only under conditions of enhanced neuronal (synaptic) activity, where endogenous adenosine levels are likely to be elevated. Since Fig. 2, like Fig. 1 , depicts an increased synaptic activity state, caffeine influences on A 2B receptors are included. Second, possible contributions from A 3 receptors are not considered. This is due to limited A 3 receptor distribution in the brain [27] and an apparent caffeine inhibitory potency toward the A 3 receptor that is lower by approximately one order of magnitude, in relation to the other 3 receptors [7] . Third, we postulated that caffeine effects toward A 1 receptors primarily involve preventing presynaptic manifestations of A 1 receptor activation (i.e., the capacity to restrict neurotransmitter release); although post-synaptic A 1 receptor blockade is given some consideration [49] . Fourth, when examining the effects of caffeine-mediated blockade of A 2A receptors on arteriolar responses during neuronal activation states, we took into account pre-and post-synaptic, astrocytic, and vascular smooth muscle A 2A receptor sites (see earlier). For A 2B receptor-related influences of caffeine on arteriolar tone, under conditions of increased synaptic activity, it seems reasonable to limit the focus to blockade of astrocytic and smooth muscle A 2B receptors.
Nevertheless, in the context of neurovascular coupling, the assumption of an A 1 receptor effect of caffeine being largely confined to presynaptic elements is bolstered by findings that topical application of the A 1 receptor antagonist, DPCPX, actually potentiates pial arteriolar dilations evoked by sciatic nerve stimulation in rats [50] . This might be explained on the basis of an A 1 receptor-linked repression of neurotransmitter (e.g., glutamate) release, during increased axonal activity, acting as a "brake" on synaptic function. The upshot of this is that A 1 receptor blockade will be accompanied by enhanced synaptic activity. In fact, there appears to be a significant A 1 receptor-related tonic inhibition of synaptic transmission [51] . This could account for the well-known arousal effects associated with caffeine consumption. However, caffeineinduced arousal was reported to be absent in A 2A receptor knockout mice [52] . Although this seems to imply an important role for A 2A receptor inhibition in the arousal response to caffeine, those findings have been questioned in a recent report [53] . On the other hand, acute caffeine administration in rats constricts pial arterioles [54] and lowers CBF in rats [55] and human subjects [56, 57] . This could be explained by the caffeine-induced loss of a basal A 2 receptor-associated vasodilating "tone". The importance of a vascular (presumably A 2 receptor) site for the vasoconstrictive actions of caffeine is underscored by findings showing that direct application of caffeine was accompanied by a ∼70% reduction in adenosine-induced dilation of iso-S58
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lated rat brain arterioles [54] . The acute effects of caffeine on vascular tone and CBF not only may be related to the presence of A 2A and A 2B receptors on vascular smooth muscle, but also on astrocytes. Thus, especially under conditions of elevated synaptic activity, blockade of astrocytic A 2 receptors could disrupt Ca 2+ signaling mechanisms, diminishing ATP release, and reducing the amount of adenosine to which arterioles are exposed. Furthermore, one also cannot ignore effects arising from caffeine blockade of A 2A (and A 1 ) receptors on synaptic membranes. During enhanced axonal activity, A 2A receptor-mediated facilitation may override A 1 receptor-mediated repression of glutamate release from nerve endings [31] . In the presence of caffeine, which blocks both receptors, it is difficult to predict what the net effect on glutamate release will be. Caffeine-associated blockade of astrocytic A 2A receptors, as depicted in Fig. 2 , may favor net glutamate uptake into astrocytes, reducing glutamate levels in the synaptic cleft. Thus, there is a measure of uncertainty regarding the net effect of caffeine on activation of postsynaptic glutamate receptors. Adding to the uncertainty, caffeine will also block post-synaptic A 1 and A 2A receptors [22] . Since this could remove adenosineassociated inhibitory influences on glutamate-related post-synaptic function, the overall net effect could be enhanced post-synaptic activity. It is tempting to speculate that caffeine blockade of post-synaptic adenosine receptors might enhance the post-synaptic electrical response to glutamate during states of elevated neural activity. This might lead to a greater spread of electrical "noise" beyond the initial site of increased axonal firing, perhaps contributing to increased heterosynaptic activity and caffeine-related arousal. Thus, the ability to maintain or increase neural activity, in the face of direct vasoconstrictive actions (caffeine blockade of VSM A 2 receptors) is consistent with findings showing neurovascular "uncoupling" in rats and humans given acute caffeine treatment [54, 56, 64] .
CHRONIC CAFFEINE EXPOSURE AND CEREBRAL PERFUSION
Although there is agreement among studies, with respect to the vasoconstrictive, CBF-lowering actions of acute caffeine treatments, the effects of chronic caffeine exposure on cerebral perfusion cannot be easily generalized. There are a number of factors one might consider regarding cerebrovascular regulation in conjunction with chronic caffeine use. Certainly, adenosine-linked factors merit prime consideration. This includes (but is not limited to), changes in adenosine receptor expression and agonist sensitivity associated with caffeine tolerance. One example is the upregulation of platelet A 2A receptor expression observed in human subjects following chronic caffeine exposure [58] . One could also consider how variations in adenosine receptor distribution, within the cerebral arterial system and the other components of the neurovascular unit, may impact on caffeine effects. A number of publications appearing over the past two decades point to cerebral A 1 (but not A 2A ) receptor upregulation and sensitization in rodents in association with chronic caffeine intake (reviewed in [59] ). Consistent with a lack of influence of chronic caffeine intake on A 2A receptor function, one study in rats revealed that the tolerance that develops toward the striatal motor stimulant effects of caffeine, with chronic caffeine intake, could not be recapitulated with prolonged administration of a selective antagonist of A 2A receptors [60] . However, the results of other investigations showed seemingly opposite effects of chronic caffeine treatment. Thus, an enhanced A 2A receptor ligand binding in the striatum was reported in one study [61] , while a downregulation of striatal A 2A mRNA and protein expression was observed in another [62] . Adding to the uncertainty, Arendash and co-workers [63] reported no changes in A 2A and A 1 expression in hippocampus and frontal cortex of mice following chronic caffeine intake. While this might reflect regional selectivity in adenosine receptor responses to chronic caffeine exposure, it should be noted that the results in the latter study were obtained in amyloid precursor protein transgenic mice, and, thus, should be viewed with some caution.
Another potentially interesting aspect of the role of adenosine receptors in caffeine tolerance development relates to the postulated presence of presynaptic A 1 -A 2A receptor heterodimers in the brain [31] , as touched upon earlier. In one postulated scenario [35] , at least in the striatum, receptor tolerance to chronic caffeine exposure affects A 2A more than A 1 receptors. This relative enhancement of A 2A receptor function could effect further inhibition of caffeine-repressed A 1 receptors. In this way, chronic caffeine exposure would favor a greater A 2A over A 1 receptor function and enhanced presynaptic activity, as opposed to caffeine-naïve rats. It might be speculated that such a scheme could be associated with a partial recovery of the repressed neurovascular coupling accompanying acute caffeine exposure. However, this co-localization of adenosine receptors is not uniformly distributed among brain regions and may simply function as a limited local "fine-tuning" mechanism [30, 31, 33] . Furthermore, the potential impact of A 1 -A 2A receptor heterodimerization as a facilitator of neurovascular coupling may only be manifested in higher brain activation states [31] . In summary, there remains a high level of uncertainty surrounding this issue, and further study is clearly warranted.
However, none of the studies cited above provided evidence regarding expression or functional changes in vascular-specific adenosine receptor populations. Based upon the earlier discussion, it is difficult to envisage chronic caffeine effects that do not involve vascular smooth muscle A 2 receptors (see [54] ). Indeed, it has been suggested that the increased CBF that occurs in human subjects within 24 h of caffeine withdrawal results from adenosine binding to a more sensitized population of receptors or a greater abundance of cerebral arterial receptors (see [65, 66] for references). Due to the lack of evidence supporting any direct adenosine A 1 receptor effects on cerebral arteriolar tone [54] , one might ascribe the apparent "upregulation" of adenosine receptor function to vascular A 2 receptors. Furthermore, in human subjects, a partial (or incomplete) tolerance to acute caffeine-related CBF reductions was found in association with chronic caffeine intake [66, 67] . While this could be a reflection of A 2A receptor upregulation (as postulated by Addicott et al. [65] ), in the absence of any data regarding A 2 receptor expression or ligand affinity in cerebral arteries and arterioles, one cannot eliminate the possibility that these chronic caffeine effects may be related to adenosine receptors residing in astrocytes or neurons. One also cannot ignore the role of altered abundance of non-adenosinergic receptor populations. For example, increased expression of brain tissue acetylcholine, serotonin, and GABA A receptors has been documented in the mouse in conjunction with chronic caffeine ingestion [59, 68] . As such, there is the possibility that chronic caffeine effects on neurovascular coupling (or vascular function in general) may arise from altered expression of nonadenosinergic receptors, or even ion channels [59, 68] , residing in one or more of the cellular elements of the neurovascular unit. These and related issues will make interesting subjects for future experimentation.
CONCLUDING REMARKS
In conclusion, caffeine can have multiple effects on cerebral arteries and arterioles, resulting in a complex influence on brain perfusion both under resting (basal) conditions and during states of increased synaptic activity (neural activation-induced hyperemia). At the levels of caffeine achieved in the circulation and brain during normal human consumption, caffeine is known to exert measurable effects on CBF. Those effects can be largely attributed to actions toward adenosine receptors and not other potential targets of caffeine, such as phosphodiesterases and ryanodine receptors. Both animal and human studies have indicated that acute caffeine exposure leads to constriction of cerebral vessels and reduced CBF, as well as diminished neurovascular coupling. It can be postulated that those effects of caffeine likely arise from inhibitory actions on A 1 , A 2A , and A 2B receptors distributed among the cellular components of the neurovascular unit -namely, neurons, astrocytes and vascular smooth muscle. The principal site of acute caffeine influence on A 1 receptors is likely presynaptic nerve endings. Yet, if this were the only target of caffeine to affect neurovascular coupling, one should observe an enhanced cerebral vasodilating response to neural/synaptic activation, as was reported by Meno et al. [50] in the presence of an A 1 receptor antagonist. Since caffeine suppresses neurovascular coupling (e.g., in the cortex [54] ), it is probable that this reflects caffeine actions toward A 2A receptors, and, perhaps to a lesser extent, A 2B receptors. The A 2 receptors contributing to the caffeine effect are likely to be found in multiple cellular sites. Indeed, A 2A receptors have been identified in presynaptic, post-synaptic, astrocytic, and vascular smooth muscle sites; whereas A 2B receptors are, at the least, expressed in astrocytes and vascular smooth muscle cells.
Attempts to understand the effects of chronic caffeine intake on cerebral hemodynamics have been confronted with more uncertainty. A principal problem here arises from a lack of consensus with respect to changes in the expression and/or adenosine sensitivity of A 1 vs A 2 receptors in association with prolonged exposure to an antagonist, like caffeine. While we cannot ignore A 1 receptor changes, there is some indirect evidence to suggest that vascular A 2A receptors might selectively upregulate during chronic caffeine exposure. This could explain the repeated observation that acute caffeine withdrawal from chronic caffeine ingestion is associated with an increase in CBF -one that is directly proportional to the daily caffeine intake immediately preceding the onset of abstinence (e.g. [69] ). However, further experimentation is clearly warranted. Such experimentation could include, in animal models, a simple verification of whether there is at least a trend toward normalization of an acutely depressed neurovas- In association with such studies, one might consider the use of conditional knockouts to characterize the participation of adenosine receptors associated with specific cellular elements within the neurovascular unit.
